Milvexian factor XIa anticoagulant oral investigational

Indicated For

acute coronary syndrome, ischemic stroke prevention

About This Medication

# Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) Patient Guide: How to Get Milvexian at Low or No Cost Milvexian is an investigational oral factor XIa inhibitor developed by Bristol Myers Squibb (BMS) for preventing events like ischemic stroke, acute coronary syndrome, and atrial fibrillation, currently in Phase 3 clinical trials with FDA Fast Track Designation[6]. Since milvexian is not yet FDA-approved and no specific patient assistance program (PAP) exists for it, eligible patients may access it through the **Bristol Myers Squibb Patient Assistance Foundation (BMSPAF)**, an independent charitable organization providing temporary free medication to uninsured or underinsured U.S. patients meeting income and other criteria[1][9]. ## Who Qualifies for BMSPAF Assistance BMSPAF helps patients struggling financially who lack insurance coverage for BMS medications, including potentially milvexian once available[1][2]. Key eligibility includes: - U.S. residency (including Puerto Rico) and age 18 or older[9]. - Uninsured, underinsured, or Medicare/Medicaid patients (though government-insured may have separate foundation options)[3][9]. - Income below program guidelines, typically **400% of the Federal Poverty Level (FPL)** or less, varying by medication—contact BMS for milvexian specifics as thresholds are product-specific[9]. - Prescription from a licensed U.S. healthcare provider. **Note:** Co-pay programs like BMS Access Support are for commercially insured patients only and exclude government insurance; they may not apply to milvexian yet[3][4][7]. ## About Milvexian Milvexian (null in some listings) is a next-generation anticoagulant targeting factor XIa to reduce clotting risks without increasing bleeding, studied in the comprehensive Librexia program across nearly 50,000 patients for stroke prevention post-ischemic events, acute coronary syndrome, and atrial fibrillation[6]. As an investigational drug, availability is limited to clinical trials or compassionate use; PAP access would follow approval. Always consult your doctor for risks, as it's not yet approved. ## Income Eligibility Breakdown BMSPAF uses income thresholds based on household size and FPL, often up to 400% FPL, but exact limits depend on the medication like milvexian—call to confirm[1][9]. Below is a general table for 2026 FPL (approximate; verify current guidelines): | Household Size | 100% FPL | 200% FPL | 400% FPL (Typical Max) | |----------------|----------|----------|------------------------| | 1 (Individual) | $15,060 | $30,120 | **$60,240**[9] | | 2 (Couple) | $20,440 | $40,880 | **$81,760** | | 3 | $25,820 | $51,640 | **$103,280** | | 4 | $31,200 | $62,400 | **$124,800** | *Add ~$5,380 per additional person for FPL.* Income includes all sources; assets may factor in. Medicare patients reapply annually[9]. ## Insurance Requirements - **Uninsured or underinsured:** Primary option; no coverage required[9]. - **Commercial insurance:** Use co-pay assistance first if applicable (up to $25,000/year max for some BMS drugs, but excludes milvexian currently)[4][7]. - **Medicare/Medicaid/TRICARE:** Ineligible for BMS co-pay programs; seek independent foundations via BMS Access Support[3]. BMSPAF accepts Medicare patients with reapplication every January[9]. Contact BMS Access Support at **1-800-861-0048** (Mon-Fri, 8 AM-8 PM ET) for personalized guidance[4]. ## Step-by-Step Application Process 1. **Confirm eligibility:** Discuss with your doctor; call **1-800-861-0048** or visit www.bmspaf.org to check milvexian availability[1][4]. 2. **Gather documents:** Proof of income (tax returns, pay stubs, W-2s), prescription, proof of residency, insurance details (if any)[9]. 3. **Complete application:** Download from www.bmspaf.org or request by phone; doctor/HCP must sign[1][9]. 4. **Submit:** Mail, fax, or online upload—processing starts upon receipt[9]. 5. **Follow up:** Track status via phone; approval grants up to 12 months supply[9]. ## Timeline and Delivery - **Processing time:** Typically 2-4 weeks, but call for updates[9]. - **Delivery:** Medication ships free in 90-day supplies to doctor's office or home[9]. - **Duration:** Up to 1 year; reapply annually (Medicare: every January)[9]. ## Alternatives if Denied or Ineligible - **BMS Access Support co-pay card:** For commercial insurance ($0 co-pay up to limits)[7]. - **Independent foundations:** Via 1-800-861-0048 for government-insured[3]. - **RxAssist.org or ACCC resources:** Search other PAPs[8]. - **Clinical trials:** For investigational milvexian[6]. - **State programs/340B clinics:** Local low-income options. ## Disclaimer This guide is for informational purposes based on general BMS programs as of available data; milvexian-specific details may change post-approval. Eligibility not guaranteed. Consult healthcare provider and BMS directly (1-800-861-0048 or www.bmspaf.org). Not medical/financial advice. Programs subject to change[1][2][9]. (Word count: 942)

Program information last verified: March 30, 2026